» Articles » PMID: 11559745

P300/CBP Proteins: HATs for Transcriptional Bridges and Scaffolds

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2001 Sep 18
PMID 11559745
Citations 442
Authors
Affiliations
Soon will be listed here.
Abstract

p300/CBP transcriptional co-activator proteins play a central role in co-ordinating and integrating multiple signal-dependent events with the transcription apparatus, allowing the appropriate level of gene activity to occur in response to diverse physiological cues that influence, for example, proliferation, differentiation and apoptosis. p300/CBP activity can be under aberrant control in human disease, particularly in cancer, which may inactivate a p300/CBP tumour-suppressor-like activity. The transcription regulating-properties of p300 and CBP appear to be exerted through multiple mechanisms. They act as protein bridges, thereby connecting different sequence-specific transcription factors to the transcription apparatus. Providing a protein scaffold upon which to build a multicomponent transcriptional regulatory complex is likely to be an important feature of p300/CBP control. Another key property is the presence of histone acetyltransferase (HAT) activity, which endows p300/CBP with the capacity to influence chromatin activity by modulating nucleosomal histones. Other proteins, including the p53 tumour suppressor, are targets for acetylation by p300/CBP. With the current intense level of research activity, p300/CBP will continue to be in the limelight and, we can be confident, yield new and important information on fundamental processes involved in transcriptional control.

Citing Articles

Dysregulation of the p300/CBP histone acetyltransferases in human cancer.

Xu L, Xuan H, Shi X Epigenomics. 2025; 17(3):193-208.

PMID: 39929233 PMC: 11812348. DOI: 10.1080/17501911.2024.2447807.


Discovery of 5-imidazole-3-methylbenz[d]isoxazole derivatives as potent and selective CBP/p300 bromodomain inhibitors for the treatment of acute myeloid leukemia.

Hu J, Tang X, Luo G, Zhang C, Wu T, Wang C Acta Pharmacol Sin. 2025; .

PMID: 39890943 DOI: 10.1038/s41401-025-01478-x.


P300/RNA polymerase II mediates induction of the teleost viral RNA sensor MDA5 through the interferon regulatory factor IRF11.

Li W, Feng Y, Teng Y, Montero A, Zhou Y, Zhang X J Biol Chem. 2025; 301(2):108193.

PMID: 39826689 PMC: 11849104. DOI: 10.1016/j.jbc.2025.108193.


Targeting CBP and p300: Emerging Anticancer Agents.

Masci D, Puxeddu M, Silvestri R, La Regina G Molecules. 2024; 29(19).

PMID: 39407454 PMC: 11482477. DOI: 10.3390/molecules29194524.


Integrating text mining with network models for successful target identification: validation in MASH-induced liver fibrosis.

Venhorst J, Hanemaaijer R, Dulos R, Caspers M, Toet K, Attema J Front Pharmacol. 2024; 15:1442752.

PMID: 39399467 PMC: 11466758. DOI: 10.3389/fphar.2024.1442752.